Bullboard - Stock Discussion Forum Arch Biopartners Inc V.ARCH

Alternate Symbol(s): ACHFF

Technology Scientific & Technical Instruments

Arch Biopartners Inc. is a late-stage clinical trial company focused on preventing acute kidney injury. The Company is developing a platform of new drugs to prevent inflammation injury in the kidneys, lungs and liver via the dipeptidase-1 (DPEP1) pathway and are relevant for many common injuries and diseases where organ inflammation is an unmet problem. The Company’s lead drug candidate is... see more

Add To Watchlist

TSXV:ARCH - Post Discussion

Arch Biopartners Inc > What's up with the selling

View:

Post by 2019champs on May 04, 2021 1:35pm

What's up with the selling

Do people not know what's going on with this company? My lord. Some crappy traders / investors. Smh

149

Comment

Comment by stocksarefun on May 04, 2021 3:33pm

Does anyone have access to Short interest data on canadian stocks? This price action is insanity.

Comment

Comment by GoldenArm on May 12, 2021 11:34am

Shhhhhh! I haven't stoppeed buying this stock so don't tell anyone about it until I'm done. Short Position Shares Short (Apr. 30, 2021) 11.04k Short Ratio (Apr. 30, 2021) 0.69 Short % of Float (Apr. 30, 2021) N/A Short % of Shares Outstanding (Apr. 30, 2021) 0.02% Shares ...more

102

Comment

Comment by 2019champs on May 12, 2021 2:27pm

Some of these guys are really going to be kicking themselves when we're trading at $10 in the near future. $50 a share isnt out of the question for a drug like this. This drug targets an unmet area. Let these sloppy sellers and sloppy algos regret it

Comment

Arch Biopartners Inc